Sugi Predict

Sugi Predict / Compounds / SCHEMBL823677

SCHEMBL823677

SCHEMBL823677

CC(=O)c1cc(F)c(F)c(F)c1

nearest known ligand 0.64

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CES2 O00748 4/20 0.64
▸ CES1 P23141 4/20 0.64
▸ MAOB P27338 2/20 0.50
▸ CA5A P35218 1/20 0.50
▸ LMNA P02545 2/20 0.41
▸ CA1 P00915 2/20 0.41
▸ CA2 P00918 2/20 0.41
▸ CA4 P22748 2/20 0.41
▸ KIF11 P52732 1/20 0.40
▸ HDAC1 Q13547 1/20 0.40
▸ HDAC6 Q9UBN7 1/20 0.40
▸ MAPK1 P28482 2/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ MAOA P21397 1/20 0.37
▸ HTT P42858 1/20 0.36
▸ RAB9A P51151 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL31124417 0.97 CES2 (0.61) CES2CES1MAOBCA5ALMNA
SCHEMBL13293382 0.86 CES2 (0.48) CES2CES1MAOBCA5ALMNA
SCHEMBL1373573 0.82 CA5A (0.54) CES2CES1MAOBCA5ALMNA
SCHEMBL13125486 0.82 HDAC1 (0.59) CES2CES1MAOBCA5ALMNA
SCHEMBL28652802 0.81 KIF11 (0.51) CES2CES1MAOBCA5AKIF11
SCHEMBL23951203 0.80 CA5A (0.46) CES2CES1MAOBCA5ALMNA
SCHEMBL18862523 0.80 CA5A (0.46) CES2CES1MAOBCA5ALMNA
SCHEMBL17041211 0.80 CA5A (0.46) CES2CES1MAOBCA5ALMNA
SCHEMBL23112583 0.80 CA5A (0.46) CES2CES1MAOBCA5ALMNA
SCHEMBL3777767 0.80 HDAC1 (0.57) CES2CES1MAOBCA5ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 225 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114950159-B Preparation method of aromatic polymer separation membrane based on super acid catalysis 南京工业大学 2023-06-06 — — CN claimed
CN-106316893-B Process for producing N- (4-acetyl-2, 6-difluorophenyl) methanesulfonamide 株式会社爱茉莉太平洋 2021-03-12 — — CN claimed
CN-109608368-B Synthesis and resolution method of N- [4- (1-aminoethyl) -2, 6-difluorophenyl ] methanesulfonamide 常州市阳光药业有限公司 2021-03-09 — — CN claimed
CN-109608368-A The synthesis of N- [4- (1- amino-ethyl) -2,6- difluorophenyl] Methanesulfomide and method for splitting 常州市阳光药业有限公司 2019-04-12 — — CN claimed
CN-106316893-A Method for preparing n-(4-acetyl-2,6-difluorophenyl)methanesulfonamide 株式会社爱茉莉太平洋 2017-01-11 — — CN claimed
US-8952083-B2 Fluorocopolymer composition and its production process ASAHI GLASS COMPANY, LIMITED (JP) 2015-02-10 — — US claimed
US-12410207-B2 Galactoside inhibitor of galectins GALECTO BIOTECH AB (DK) 2025-09-09 — — US disclosed
WO-2025092986-A1 POLYCYCLIC COMPOUND, PREPARATION METHODS AND MEDICINAL USES THEREOF JIANGSU HANSOH PHARMACEUTICAL GROUP CO., LTD. (CN) 2025-05-08 — — WO disclosed
CN-119707964-A Preparation method of (8-bromoindolizine-3-yl) (3, 4, 5-trifluoro phenyl) ketone 无锡科华生物科技有限公司 2025-03-28 — — CN disclosed
US-12258323-B2 Dihydrooxadiazinones BAYER AKTIENGESELLSCHAFT (DE) 2025-03-25 — — US disclosed
CN-119424423-A 4-Aminobut-2-enamide derivatives and salts thereof 大鹏药品工业株式会社 2025-02-14 — — CN disclosed
CN-118852011-A Substituted tolyl fungicides FMC公司 2024-10-29 — — CN disclosed
US-20240324596-A1 SUBSTITUTED TOLYL FUNGICIDES FMC CORPORATION 2024-10-03 — — US disclosed
US-20020151554-A1 Diaminothiazoles having antiproliferative activity CHEN LI (US) 2002-10-17 — — US disclosed
WO-2002057261-A2 DIAMINOTHIAZOLES AND THEIR USE AS INHIBITORS OF CYCLIN-DEPENDENT KINASE F. HOFFMANN-LA ROCHE AG (CH) 2002-07-25 — — WO disclosed
US-6187777-B1 PYRROLO(3,2-D)PYRIMIDINE DERIVATIVES; NEUROPEPTIDE Y AND CORTICOTROPIN RELEASING FACTOR MODULATORS; DIETETICS; ANTIDIABETIC, ANTIINFLAMMATORY, AND ANTITUMOR AGENTS AMGEN INC. 2001-02-13 — — US disclosed
EP-0387032-B1 TRIFLUOROBENZENE DERIVATIVES AND LIQUID CRYSTAL COMPOSITIONS CONTAINING THE SAME CHISSO CORP (JP) 1993-06-16 — — EP disclosed
US-5032313-A Trifluorobenzene derivative and liquid crystal composition containing the same CHISSO CORPORATION (JP) 1991-07-16 — — US disclosed
EP-0387032-A1 Trifluorobenzene derivatives and liquid crystal compositions containing the same Chisso Corporation (JP) 1990-09-12 — — EP disclosed
EP-0328669-A1 CHALCONE DERIVATIVE COMPOUNDS NIPPON OIL AND FATS COMPANY, LIMITED (JP) 1989-08-23 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020151554-A1 Diaminothiazoles having antiproliferative activity CDK4, CDK2, CDKL4 CES2 4046/4885CES1 4153/4885MAOB 3182/4885
US-20240324596-A1 SUBSTITUTED TOLYL FUNGICIDES TH, NAT1, CYP1B1 CES2 1362/4885CES1 1625/4885MAOB 439/4885
US-12258323-B2 Dihydrooxadiazinones CCND2, CCNT2, CCND1 CES2 4389/4885CES1 2438/4885MAOB 840/4885
US-12410207-B2 Galactoside inhibitor of galectins LGALS1, LGALS3, LGALS2 CES2 4072/4885CES1 1155/4885MAOB 4095/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.